TWA
TCI Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-154
| Closed | -$15K | – | 472 |
|
|
2023
Q1 | $15K | Sell |
154
-93
| -38% | -$9.04K | ﹤0.01% | 851 |
|
|
2022
Q4 | $25.6K | Buy |
247
+100
| +68% | +$10.3K | ﹤0.01% | 596 |
|
|
2022
Q3 | $12K | Buy |
147
+7
| +5% | +$571 | ﹤0.01% | 896 |
|
|
2022
Q2 | $12K | Hold |
140
| – | – | ﹤0.01% | 886 |
|
|
2022
Q1 | $11K | Sell |
140
-37
| -21% | -$2.91K | ﹤0.01% | 1024 |
|
|
2021
Q4 | $16K | Buy |
177
+15
| +9% | +$1.36K | ﹤0.01% | 806 |
|
|
2021
Q3 | $13K | Hold |
162
| – | – | ﹤0.01% | 891 |
|
|
2021
Q2 | $14K | Buy |
162
+30
| +23% | +$2.59K | ﹤0.01% | 723 |
|
|
2021
Q1 | $10K | Buy |
132
+72
| +120% | +$5.46K | ﹤0.01% | 825 |
|
|
2020
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 827 |
|
|
2020
Q3 | $5K | Hold |
60
| – | – | ﹤0.01% | 734 |
|
|
2020
Q2 | $7K | Hold |
60
| – | – | ﹤0.01% | 633 |
|
|
2020
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 689 |
|
|
2019
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 835 |
|
|
2019
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 847 |
|
|
2019
Q2 | $5K | Hold |
60
| – | – | ﹤0.01% | 749 |
|
|
2019
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 766 |
|
|
2018
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 746 |
|
|
2018
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 724 |
|
|
2018
Q2 | $6K | Hold |
60
| – | – | ﹤0.01% | 728 |
|
|
2018
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 721 |
|
|
2017
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 769 |
|
|
2017
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 687 |
|
|
2017
Q2 | $5K | Hold |
60
| – | – | ﹤0.01% | 742 |
|
|
2017
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 704 |
|
|
2016
Q4 | $5K | Buy |
+60
| New | +$5K | ﹤0.01% | 761 |
|
|
2016
Q1 | – | Sell |
-6
| Closed | -$1K | – | 1329 |
|
|
2015
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 920 |
|